Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the Biotech Week Boston from 15-18 September 2025 in Boston, USA.
Partnering Week in China 2025
Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.